It might seem like every drug likely to be abused by the addicted is kept under lock and key to protect the public. Gabapentin seems to be an exception.
A panel of experts for the FDA rejected the sale of a new extended-release form of oxycodone that dyes the mouth or nose blue when it is abused. Is a blue dye a good method of deterring drug abuse?
Most parents are familiar with the tendency of youth to start using alcohol or marijuana. It’s a good bet, however, that few are ready to think of their teenaged child abusing Xanax, the anti-anxiety drug, especially considering how dangerous this drug is.
A few weeks ago, this blog featured an article on the lawsuits being filed against major pharmaceutical companies such as Purdue Pharma, Endo International, Teva Pharmaceutical Industries, Depomed, Janssen/Johnson & Johnson and others. In the following weeks, even more states, counties and cities have initiated legal action against these companies and others who manufacture, market or distribute these addictive pills.
A new analysis of prescribing patterns for opioid painkillers revealed that three-quarters of these pills go to just 10% of patients. Might a careful analysis of the needs of this small group help curb overprescribing?
When Tiger Woods was found asleep in his car due to a mix of prescription drugs he’d consumed and police took him into custody, this intervention may have saved his life. Compare his story to Heath Ledger’s.
In April 2017, the Drug Enforcement Administration (DEA) sponsored a National Prescription Drug Take Back Day to collect unused prescriptions across the country. The staggering quantities of drugs collected seems like conclusive proof that doctors must still be prescribing too many drugs.